Stable compositions of atorvastatin prepared with wet granulation
AU2007240176A1
New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
US2007203212A1
Method of treating osteoarthritis
ZA200609688B
Preparation of pregabalin and related compounds
ZA200609448B
Liquid dispensing device
EP1957452A1
Novel forms of [r-(r*,r*)]-2-(4-fluorophenyl)-b,b-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-hept anoic acid magnesium
ZA200608481B
Compositions and methods for treating pathological infections
MX2008003053A
Formulation and method for enhancement of gastrointestinal absorption of pharmaceutical agents.
EP1912937A1
Novel substituted azetidinones
US2006247231A1
Amide and ester matrix metalloproteinase inhibitors
WO2007007149A1
Androgen modulators
TW200708499A
Process for producing ethers
WO2006134469A1
Methods of preparing mek inhibitor
WO2006123238A1
Confectionery products for the treatment of dry mouth
CA2606847A1
Antibacterial agents
TW200724139A
Androgen modulators
WO2006114705A1
Automated birefringence analysis and targeting system
CN101189237A
Tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia
MX2007010602A
Crystalline forms of a known pyrrolidine factor xa inhibitor.